Tag: DC Bead Lumi
First European patients treated with DC Bead Lumi radiopaque drug-eluting beads
Two patients were treated for hepatocellular carcinoma and one patient was treated for malignant colorectal cancer metastasised to the liver.
DC Bead Lumi is...
BTG receives CE mark for DC Bead Lumi
BTG has received Class III CE mark certification for DC Bead Lumi, the first commercially available radiopaque drug-eluting bead (DEB) in the EU which...
Canada first country to get DC Bead Lumi treatment for liver...
BTG International Canada has announced the commercial launch of DC Bead Lumi in Canada. The launch represents the first market commercialisation of DC Bead...
